Cetyltrimethylammonium naproxenate

DB15877ExperimentalSmall molecule

Cetyltrimethylammonium naproxenate is an anti-inflammatory and antiseptic agent indicated to treat mouth inflammation and pain , including that caused by tooth extraction.

Mechanism: Cetyltrimethylammonium naproxenate is a a cetrimonium (cetyltrimethylammonium) salt containing naproxen, a non-steroidal anti-inflammatory agent. Once administered, naproxen is released and mediates its anti-inflammatory actions via cyclo-oxygenase inhibition.
Curator reviewed · 1 reference
Formula / weight: C₃₃H₅₅NO₃ · 513.807 g/mol (avg)
Also known as: Cetyl trimethylammonium naproxenate

Resolves to

Compound

UNII5333CM4X3GCAS102580-74-5

Structure

InChIKeyRNQBLUNNAYFBIW-NPULLEENSA-MSMILESCOC1=CC2=CC=C(C=C2C=C1)[C@H](C)C([O-])=O.CCCCCCCCCCCCCCCC[N+](C)(C)C

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Structured indicationsCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

4Marketed productsAcross 1 country and 2 labellers

3+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Cetyltrimethylammonium naproxenate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account